Axsome Therapeutics (AXSM) Goodwill & Intangibles (2022 - 2026)

Axsome Therapeutics' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $51.0 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 32.73% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $51.0 million (down 32.73% YoY), while the FY2025 annual figure was $75.8 million, up 28.78% from the prior year.
• Goodwill & Intangibles came in at $51.0 million for Q1 2026 at Axsome Therapeutics, down from $75.8 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $75.8 million in Q3 2025 to a low of $51.0 million in Q1 2026.
• A 5-year average of $69.7 million and a median of $72.8 million in 2022 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles increased 28.78% in 2025 and plunged 32.73% in 2026, its largest moves.
• Axsome Therapeutics' Goodwill & Intangibles stood at $70.0 million in 2022, then fell by 6.7% to $65.3 million in 2023, then retreated by 9.79% to $58.9 million in 2024, then advanced by 28.78% to $75.8 million in 2025, then tumbled by 32.77% to $51.0 million in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $51.0 million, $75.8 million, and $75.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison